Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label was updated to v3.5.4, indicating a new internal release of the page rendering.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page footer software revision was updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check70 days agoChange DetectedLocations updated: added Hôpital de l'Archet, Charité - Universitätsmedizin Berlin, and Queen Elizabeth Hospital; removed HOP l'Archet, Charité Universitätsmedizin Berlin KöR, and Queen Elizabeth Hospital-Kota Kinabalu-40735. An EU CTIS number (2023-509216-28-00) was added along with a data-sharing link.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.